NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
1.210
+0.030 (2.54%)
At close: Sep 18, 2025, 4:00 PM EDT
1.210
0.00 (0.00%)
After-hours: Sep 18, 2025, 7:20 PM EDT
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $30.30 million as of September 18, 2025. Its market cap has increased by 74.86% in one year.
Market Cap
30.30M
Enterprise Value
29.39M
1-Year Change
74.86%
Ranking
Category
Stock Price
$1.21
Market Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $30.30M, a decrease of -53.10%. That is a compound annual growth rate of -18.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 29.55M | 6.49% |
| Dec 31, 2024 | 27.75M | 158.68% |
| Dec 29, 2023 | 10.73M | -24.68% |
| Dec 30, 2022 | 14.24M | -46.24% |
| Dec 31, 2021 | 26.49M | -59.00% |
| Dec 9, 2021 | 64.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.91B |
| Johnson & Johnson | 419.44B |
| AbbVie | 392.16B |
| UnitedHealth Group | 303.24B |
| Novo Nordisk | 275.39B |
| AstraZeneca | 236.44B |
| Novartis AG | 236.39B |
| Abbott Laboratories | 234.21B |